Giulia Fabbri

Giulia Fabbri is a Senior Director of Translational Medicine Oncology Strategy at AstraZeneca, where they lead efforts within the Enhertu franchise. They previously served as Director and Associate Director in Translational Medicine at the same company. Giulia’s academic background includes a Ph.D. in Developmental Medicine and Programming Sciences, as well as an M.D. in Hematology Oncology, both from Università degli Studi di Padova. Additionally, they were a Postdoctoral Research Fellow at Columbia University, where their research contributed significantly to understanding the genetic determinants and evolution of chronic lymphocytic leukemia.